Tamsulosin OCAS

DRUG2 trials

Sponsors

Astellas Pharma Inc

Conditions

Benign Prostatic HyperplasiaLower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH)

Phase 4

A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.

CompletedNCT00379067

Astellas Pharma IncBenign Prostatic Hyperplasia

Start: 2005-10-31End: 2006-11-30Updated: 2014-10-10

A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional Formulation

CompletedNCT02180789

Astellas Pharma IncLower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH)

Start: 2013-03-31End: 2015-01-31Updated: 2015-11-18